Skip to main content

Table 1 Gains and losses of DNA segments larger than 0.5 Mb in 30 chromophobe RCCs and 42 ROs.

From: High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas

Tumor

Chromosomal location

Size, Mb

G/L/HL*

Genes

chRCC

1p36.21-q44

232.12

L

 

RO

1p36.33-p36.21

14.6

L

 

chRCC

1p22.1

0.71

HL

MTF2, TMED5, NY-SAR-41, DR1, BCAR3

RO

1q42.2-q44

18.1

L

 

chRCC

2q13

0.95

HL

BENE, NPHP1, LIMS3, RABP2L1, BUB1

chRCC

2q22.3-q23.2

5.9

HL

 

RO

3p14.3

1.10

G

IL17RD, HESX1, APPL, FLJ44290, ARF4, SLMAP, FLNB

RO

3q13.11

2.72

L

ALCAM, CBLB

chRCC

5p14.1

1.54

G

CDH9

RO

5q21.3-q35.3

71.48

G

 

chRCC

6p22.2-q27

145.86

L

 

RO

6q13-q27

96.3

L

 

RO

6q15

0.74

G

GABRR2, UBE2J1, RRAGD, ANKRD6, MDN1, CASP8AP2, OX62, BACH2

RO

6q24.2-q24.3

0.69

G

EPM2A, FBXO30, SHPRH

RO

7q11.22-q11.23

5.65

G

 

RO

7q11.22-q11.23

3.30

G

 

chRCC

7q11.22-q11.23

0.92

G

CALN1

RO

7q22.1

2.78

G

 

RO

7q34

0.52

G

TIF1, Loc136306, ATP6V0A4

RO

9p24.3-p23

31.65

G

 

RO

9q22.1-q33.2

32.75

L

 

RO

10p15.3-p11.1

38.92

G

 

chRCC

10q11.22

0.63

G

PPYR1, ANXA8

RO

10q11.23-q21.1

1.4

L

 

RO

10q11.23-q21.1

10.2

L

 

chRCC

10q11.23-q22.3

29.17

HL

 

RO

10q21.1-q26.3

78.1

L

 

RO

10q21.1-q26.3

78.1

L

 

RO

10q22.3

1.71

G

 

RO

11p15.2-p15.1

1.2

L

SOX6

RO

11p15.5-p12

43.10

L

 

chRCC

11p15.5-p12

37,64

L

 

RO

11p11.2

0.52

G

OR4X2, OR4X1, OR4S1, OR4C3, OR4A47

RO

11p11.2

0.40

G

 

RO

11p11.2-p11.12

0.63

G

 

RO

11q13.2

2.07

G

 

RO

11q22.3-q23.1

2.18

L

 

chRCC

12p13.33-p12.1

22.49

L

 

chRCC

12p13.33-p12.1

24.61

L

 

RO

12p13.33-p11.1

32.76

G

 

chRCC

12p13.2-p11.21

20.49

L

 

chRCC

12q13.13-q21.1

20.12

G

 

RO

12q13.2-q24.33

79.05

G

 

RO

14q31.3-q32.33

22,4

L

 

chRCC

15q13.3

1.01

G

CHRNA7, ARGHAP11A

RO

16p13.3

1.57

G

 

chRCC

17p13.3-q23.3

59.77

L

 

chRCC

18q22.2-q23

10.32

G

 

RO

20p13-p11.1

26.22

G

 

chRCC

20q11.1-q11.22

4.30

L

 

chRCC

20q13.2-q13.33

10.01

L

 

chRCC

21q21.3-q22.11

0.59

HL

CLDN17, CLDN8, Loc138818, KRTAP13-1, KRTAP19-1, KRTAP19-3

chRCC

22q11.1-q12.3

16.5

L

 

chRCC

Xp22.33-q22.3

105.26

L

 

RO

Xq13.3-q21.1

1.76

G

 
  1. * G – gain, L – loss, HL – homozygous loss